Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Pre-Open Stock Movers 03/23: (SQNM) (IONS) (AFFX) Higher; (SAGE) (SUNE) (KKD) Lower (more...)
-
-
-
-
-
-
-
Gilead (GILD), AbbVie (ABBV) Buy Ratings Maintained at Deutsche Bank Following Merck (MRK) HCV Data
-
-
-
-
-
-
-
Market Wrap: U.S. Auto Sales Surge in Jan.; Oil Prices Continue Adding Gains; Office Goods Retailer M&A Nears
-
-
-
-
-
-
-
Express Scripts Decision in Hepatitis C Hints at Biosimilar Price War, Says Analyst (ABBV) (ESRX) (GILD)
-
-
-
-
-
-
-
Celgene (CELG), Gilead Sciences (GILD) Added to Short-Term Buy List at Deutsche Bank - Bloomberg
-
-
-
-
-
-
-
Streetinsider.com's Hot Lunchtime Reads 03/24: (AAPL) (IBB) (RNN) (CELG)
-
-
-
-
-
-
-
Biogen (BIIB), Celgene (CELG), and Gilead (GILD) Price Targets Raised at Deutsche Bank
-
55,975 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

